XKRX035810
Market cap122mUSD
Jan 08, Last price
2,750.00KRW
1D
-1.26%
1Q
3.38%
Jan 2017
-55.21%
Name
Easy Holdings Co Ltd
Chart & Performance
Profile
EASY HOLDINGS Co., Ltd. operates in the biological resource industry. The company is involved in manufacturing and selling of natural antibiotic substitutes, environmental improvement agents, and microbial testing kit. It provides agricultural and livestock foodstuffs; and feed additives. The company is also involved in the biotechnology; feed solution; and agro livestock infrastructure. In addition, it engages in the provision of processed meat products; and investment activities. The company was founded in 1988 and is based in Seoul, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 3,119,160,305 3.62% | 3,010,255,249 51.72% | |||||||
Cost of revenue | 2,859,285,402 | 2,783,871,269 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 259,874,903 | 226,383,979 | |||||||
NOPBT Margin | 8.33% | 7.52% | |||||||
Operating Taxes | 17,359,388 | 27,505,262 | |||||||
Tax Rate | 6.68% | 12.15% | |||||||
NOPAT | 242,515,515 | 198,878,718 | |||||||
Net income | 26,515,470 132.94% | 11,383,096 -49.49% | |||||||
Dividends | (11,991,376) | (9,817,834) | |||||||
Dividend yield | 5.79% | 5.36% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 807,236,126 | 1,003,645,945 | |||||||
Long-term debt | 223,091,758 | 150,336,391 | |||||||
Deferred revenue | 11,778,187 | 12,088,276 | |||||||
Other long-term liabilities | 123,546,277 | 123,156,335 | |||||||
Net debt | 458,064,123 | 430,074,111 | |||||||
Cash flow | |||||||||
Cash from operating activities | 73,614,765 | (35,961,121) | |||||||
CAPEX | (70,536,331) | (109,990,413) | |||||||
Cash from investing activities | (23,669,288) | (93,279,052) | |||||||
Cash from financing activities | (139,999,793) | 216,140,331 | |||||||
FCF | 215,986,468 | 68,775,794 | |||||||
Balance | |||||||||
Cash | 329,136,589 | 495,545,971 | |||||||
Long term investments | 243,127,171 | 228,362,253 | |||||||
Excess cash | 416,305,745 | 573,395,462 | |||||||
Stockholders' equity | 837,461,468 | 783,458,230 | |||||||
Invested Capital | 1,757,430,073 | 1,706,530,006 | |||||||
ROIC | 14.00% | 12.24% | |||||||
ROCE | 11.82% | 9.81% | |||||||
EV | |||||||||
Common stock shares outstanding | 65,136 | 65,136 | |||||||
Price | 3,180.00 13.17% | 2,810.00 -30.10% | |||||||
Market cap | 207,133,068 13.17% | 183,032,680 -26.08% | |||||||
EV | 1,109,924,754 | 1,064,862,535 | |||||||
EBITDA | 341,501,062 | 302,601,503 | |||||||
EV/EBITDA | 3.25 | 3.52 | |||||||
Interest | 57,823,924 | 34,877,197 | |||||||
Interest/NOPBT | 22.25% | 15.41% |